Leveraging Real-World Evidence in Disease-Management Decision-Making with a Total Cost of Care Estimator. Article Swipe
Thanh-Nghia Nguyen
,
Jeffrey Trocio
,
Stacey Kowal
,
Cheryl P Ferrufino
,
Julie Munakata
,
Dell South
·
YOU?
·
· 2016
· Open Access
·
YOU?
·
· 2016
· Open Access
·
The use of the TCoC estimator supports population health management by providing real-world evidence benchmark data on NVAF disease burden and by quantifying the potential value of disease-management activities in shifting cost trends.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://pubmed.ncbi.nlm.nih.gov/28465775
- OA Status
- green
- Cited By
- 6
- References
- 23
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2578204178
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2578204178Canonical identifier for this work in OpenAlex
- Title
-
Leveraging Real-World Evidence in Disease-Management Decision-Making with a Total Cost of Care Estimator.Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2016Year of publication
- Publication date
-
2016-12-01Full publication date if available
- Authors
-
Thanh-Nghia Nguyen, Jeffrey Trocio, Stacey Kowal, Cheryl P Ferrufino, Julie Munakata, Dell SouthList of authors in order
- Landing page
-
https://pubmed.ncbi.nlm.nih.gov/28465775Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/5394558Direct OA link when available
- Concepts
-
Health care, Disease management, Population, Pharmacy, Actuarial science, Managed care, Psychological intervention, Medicine, Operations management, Business, Disease, Economics, Nursing, Environmental health, Parkinson's disease, Economic growth, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 1, 2022: 1, 2021: 1, 2018: 1, 2017: 1Per-year citation counts (last 5 years)
- References (count)
-
23Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2578204178 |
|---|---|
| doi | |
| ids.mag | 2578204178 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/28465775 |
| ids.openalex | https://openalex.org/W2578204178 |
| fwci | 1.93954859 |
| type | article |
| title | Leveraging Real-World Evidence in Disease-Management Decision-Making with a Total Cost of Care Estimator. |
| biblio.issue | 9 |
| biblio.volume | 9 |
| biblio.last_page | 485 |
| biblio.first_page | 475 |
| topics[0].id | https://openalex.org/T10804 |
| topics[0].field.id | https://openalex.org/fields/20 |
| topics[0].field.display_name | Economics, Econometrics and Finance |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/2 |
| topics[0].domain.display_name | Social Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2002 |
| topics[0].subfield.display_name | Economics and Econometrics |
| topics[0].display_name | Health Systems, Economic Evaluations, Quality of Life |
| topics[1].id | https://openalex.org/T10391 |
| topics[1].field.id | https://openalex.org/fields/20 |
| topics[1].field.display_name | Economics, Econometrics and Finance |
| topics[1].score | 0.9976000189781189 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2002 |
| topics[1].subfield.display_name | Economics and Econometrics |
| topics[1].display_name | Healthcare Policy and Management |
| topics[2].id | https://openalex.org/T11792 |
| topics[2].field.id | https://openalex.org/fields/20 |
| topics[2].field.display_name | Economics, Econometrics and Finance |
| topics[2].score | 0.9907000064849854 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2002 |
| topics[2].subfield.display_name | Economics and Econometrics |
| topics[2].display_name | Pharmaceutical Economics and Policy |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C160735492 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6033759713172913 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q31207 |
| concepts[0].display_name | Health care |
| concepts[1].id | https://openalex.org/C2982889124 |
| concepts[1].level | 4 |
| concepts[1].score | 0.5093756914138794 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q107439039 |
| concepts[1].display_name | Disease management |
| concepts[2].id | https://openalex.org/C2908647359 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5045722723007202 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[2].display_name | Population |
| concepts[3].id | https://openalex.org/C104863432 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4623049795627594 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q614304 |
| concepts[3].display_name | Pharmacy |
| concepts[4].id | https://openalex.org/C162118730 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4565320909023285 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1128453 |
| concepts[4].display_name | Actuarial science |
| concepts[5].id | https://openalex.org/C2780265253 |
| concepts[5].level | 3 |
| concepts[5].score | 0.44900378584861755 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1416012 |
| concepts[5].display_name | Managed care |
| concepts[6].id | https://openalex.org/C27415008 |
| concepts[6].level | 2 |
| concepts[6].score | 0.419874906539917 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7256382 |
| concepts[6].display_name | Psychological intervention |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.3888029456138611 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C21547014 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3781042695045471 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1423657 |
| concepts[8].display_name | Operations management |
| concepts[9].id | https://openalex.org/C144133560 |
| concepts[9].level | 0 |
| concepts[9].score | 0.3508661091327667 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q4830453 |
| concepts[9].display_name | Business |
| concepts[10].id | https://openalex.org/C2779134260 |
| concepts[10].level | 2 |
| concepts[10].score | 0.29875245690345764 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[10].display_name | Disease |
| concepts[11].id | https://openalex.org/C162324750 |
| concepts[11].level | 0 |
| concepts[11].score | 0.21443378925323486 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[11].display_name | Economics |
| concepts[12].id | https://openalex.org/C159110408 |
| concepts[12].level | 1 |
| concepts[12].score | 0.15707647800445557 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q121176 |
| concepts[12].display_name | Nursing |
| concepts[13].id | https://openalex.org/C99454951 |
| concepts[13].level | 1 |
| concepts[13].score | 0.1425696313381195 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[13].display_name | Environmental health |
| concepts[14].id | https://openalex.org/C2779734285 |
| concepts[14].level | 3 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11085 |
| concepts[14].display_name | Parkinson's disease |
| concepts[15].id | https://openalex.org/C50522688 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q189833 |
| concepts[15].display_name | Economic growth |
| concepts[16].id | https://openalex.org/C142724271 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[16].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/health-care |
| keywords[0].score | 0.6033759713172913 |
| keywords[0].display_name | Health care |
| keywords[1].id | https://openalex.org/keywords/disease-management |
| keywords[1].score | 0.5093756914138794 |
| keywords[1].display_name | Disease management |
| keywords[2].id | https://openalex.org/keywords/population |
| keywords[2].score | 0.5045722723007202 |
| keywords[2].display_name | Population |
| keywords[3].id | https://openalex.org/keywords/pharmacy |
| keywords[3].score | 0.4623049795627594 |
| keywords[3].display_name | Pharmacy |
| keywords[4].id | https://openalex.org/keywords/actuarial-science |
| keywords[4].score | 0.4565320909023285 |
| keywords[4].display_name | Actuarial science |
| keywords[5].id | https://openalex.org/keywords/managed-care |
| keywords[5].score | 0.44900378584861755 |
| keywords[5].display_name | Managed care |
| keywords[6].id | https://openalex.org/keywords/psychological-intervention |
| keywords[6].score | 0.419874906539917 |
| keywords[6].display_name | Psychological intervention |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.3888029456138611 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/operations-management |
| keywords[8].score | 0.3781042695045471 |
| keywords[8].display_name | Operations management |
| keywords[9].id | https://openalex.org/keywords/business |
| keywords[9].score | 0.3508661091327667 |
| keywords[9].display_name | Business |
| keywords[10].id | https://openalex.org/keywords/disease |
| keywords[10].score | 0.29875245690345764 |
| keywords[10].display_name | Disease |
| keywords[11].id | https://openalex.org/keywords/economics |
| keywords[11].score | 0.21443378925323486 |
| keywords[11].display_name | Economics |
| keywords[12].id | https://openalex.org/keywords/nursing |
| keywords[12].score | 0.15707647800445557 |
| keywords[12].display_name | Nursing |
| keywords[13].id | https://openalex.org/keywords/environmental-health |
| keywords[13].score | 0.1425696313381195 |
| keywords[13].display_name | Environmental health |
| language | en |
| locations[0].id | pmid:28465775 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S4306525036 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | PubMed |
| locations[0].source.host_organization | https://openalex.org/I1299303238 |
| locations[0].source.host_organization_name | National Institutes of Health |
| locations[0].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | American health & drug benefits |
| locations[0].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28465775 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:5394558 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Am Health Drug Benefits |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5394558 |
| indexed_in | pubmed |
| authorships[0].author.id | https://openalex.org/A5082076915 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2373-669X |
| authorships[0].author.display_name | Thanh-Nghia Nguyen |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[0].affiliations[0].raw_affiliation_string | Director, Payer Channel Access, Pfizer Innovative Health, New York, NY. |
| authorships[0].institutions[0].id | https://openalex.org/I180857899 |
| authorships[0].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Pfizer (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Thanh-Nghia Nguyen |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Director, Payer Channel Access, Pfizer Innovative Health, New York, NY. |
| authorships[1].author.id | https://openalex.org/A5050220227 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Jeffrey Trocio |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I189718659, https://openalex.org/I4210133813 |
| authorships[1].affiliations[0].raw_affiliation_string | Director, Global Health & Value-Health Outcomes and Evidence, Pfizer Innovative Health. |
| authorships[1].institutions[0].id | https://openalex.org/I4210133813 |
| authorships[1].institutions[0].ror | https://ror.org/047933096 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210133813 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | Health Economics and Outcomes Research (United Kingdom) |
| authorships[1].institutions[1].id | https://openalex.org/I189718659 |
| authorships[1].institutions[1].ror | https://ror.org/04x4v8p40 |
| authorships[1].institutions[1].type | company |
| authorships[1].institutions[1].lineage | https://openalex.org/I180857899, https://openalex.org/I189718659 |
| authorships[1].institutions[1].country_code | GB |
| authorships[1].institutions[1].display_name | Pfizer (United Kingdom) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jeffrey Trocio |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Director, Global Health & Value-Health Outcomes and Evidence, Pfizer Innovative Health. |
| authorships[2].author.id | https://openalex.org/A5078626931 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6018-6052 |
| authorships[2].author.display_name | Stacey Kowal |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210108991 |
| authorships[2].affiliations[0].raw_affiliation_string | Principal, Health Economics & Outcomes Research, IMS Health, Fairfax, VA. |
| authorships[2].institutions[0].id | https://openalex.org/I4210108991 |
| authorships[2].institutions[0].ror | https://ror.org/01mk44223 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210108991 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | IQVIA (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Stacey Kowal |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Principal, Health Economics & Outcomes Research, IMS Health, Fairfax, VA. |
| authorships[3].author.id | https://openalex.org/A5109161756 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6678-3568 |
| authorships[3].author.display_name | Cheryl P Ferrufino |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210133813 |
| authorships[3].affiliations[0].raw_affiliation_string | Senior Consultant, Health Economics & Outcomes Research, IMS Health. |
| authorships[3].institutions[0].id | https://openalex.org/I4210133813 |
| authorships[3].institutions[0].ror | https://ror.org/047933096 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210133813 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | Health Economics and Outcomes Research (United Kingdom) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Cheryl P Ferrufino |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Senior Consultant, Health Economics & Outcomes Research, IMS Health. |
| authorships[4].author.id | https://openalex.org/A5108507039 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Julie Munakata |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210133813 |
| authorships[4].affiliations[0].raw_affiliation_string | Senior Principal, Health Economics & Outcomes Research, IMS Health. |
| authorships[4].institutions[0].id | https://openalex.org/I4210133813 |
| authorships[4].institutions[0].ror | https://ror.org/047933096 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210133813 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | Health Economics and Outcomes Research (United Kingdom) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Julie Munakata |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Senior Principal, Health Economics & Outcomes Research, IMS Health. |
| authorships[5].author.id | https://openalex.org/A5088559178 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Dell South |
| authorships[5].countries | GB |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I189718659 |
| authorships[5].affiliations[0].raw_affiliation_string | Executive Director, Medical Affairs, Pfizer Innovative Health. |
| authorships[5].institutions[0].id | https://openalex.org/I189718659 |
| authorships[5].institutions[0].ror | https://ror.org/04x4v8p40 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I180857899, https://openalex.org/I189718659 |
| authorships[5].institutions[0].country_code | GB |
| authorships[5].institutions[0].display_name | Pfizer (United Kingdom) |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Dell South |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Executive Director, Medical Affairs, Pfizer Innovative Health. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5394558 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Leveraging Real-World Evidence in Disease-Management Decision-Making with a Total Cost of Care Estimator. |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T04:12:42.849631 |
| primary_topic.id | https://openalex.org/T10804 |
| primary_topic.field.id | https://openalex.org/fields/20 |
| primary_topic.field.display_name | Economics, Econometrics and Finance |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/2 |
| primary_topic.domain.display_name | Social Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2002 |
| primary_topic.subfield.display_name | Economics and Econometrics |
| primary_topic.display_name | Health Systems, Economic Evaluations, Quality of Life |
| related_works | https://openalex.org/W4246727323, https://openalex.org/W2007907621, https://openalex.org/W4285744524, https://openalex.org/W2168506491, https://openalex.org/W631483513, https://openalex.org/W2094583993, https://openalex.org/W2063910949, https://openalex.org/W2109656835, https://openalex.org/W2767064241, https://openalex.org/W2395161793 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2022 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2021 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2018 |
| counts_by_year[3].cited_by_count | 1 |
| counts_by_year[4].year | 2017 |
| counts_by_year[4].cited_by_count | 1 |
| counts_by_year[5].year | 2016 |
| counts_by_year[5].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:5394558 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Am Health Drug Benefits |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5394558 |
| primary_location.id | pmid:28465775 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S4306525036 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | PubMed |
| primary_location.source.host_organization | https://openalex.org/I1299303238 |
| primary_location.source.host_organization_name | National Institutes of Health |
| primary_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | American health & drug benefits |
| primary_location.landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28465775 |
| publication_date | 2016-12-01 |
| publication_year | 2016 |
| referenced_works | https://openalex.org/W3025048258, https://openalex.org/W2578204178, https://openalex.org/W2108790161, https://openalex.org/W4293084779, https://openalex.org/W2028025254, https://openalex.org/W2079028566, https://openalex.org/W1989619289, https://openalex.org/W2315263735, https://openalex.org/W2011936209, https://openalex.org/W2553529551, https://openalex.org/W2013433912, https://openalex.org/W1983737402, https://openalex.org/W2402622037, https://openalex.org/W1983651981, https://openalex.org/W2132031192, https://openalex.org/W2120214926, https://openalex.org/W2163051647, https://openalex.org/W2143341677, https://openalex.org/W2151074096, https://openalex.org/W2132505348, https://openalex.org/W2141963295, https://openalex.org/W2170350621, https://openalex.org/W2095416337 |
| referenced_works_count | 23 |
| abstract_inverted_index.by | 10, 21 |
| abstract_inverted_index.in | 29 |
| abstract_inverted_index.of | 2, 26 |
| abstract_inverted_index.on | 16 |
| abstract_inverted_index.The | 0 |
| abstract_inverted_index.and | 20 |
| abstract_inverted_index.the | 3, 23 |
| abstract_inverted_index.use | 1 |
| abstract_inverted_index.NVAF | 17 |
| abstract_inverted_index.TCoC | 4 |
| abstract_inverted_index.cost | 31 |
| abstract_inverted_index.data | 15 |
| abstract_inverted_index.value | 25 |
| abstract_inverted_index.burden | 19 |
| abstract_inverted_index.health | 8 |
| abstract_inverted_index.disease | 18 |
| abstract_inverted_index.trends. | 32 |
| abstract_inverted_index.evidence | 13 |
| abstract_inverted_index.shifting | 30 |
| abstract_inverted_index.supports | 6 |
| abstract_inverted_index.benchmark | 14 |
| abstract_inverted_index.estimator | 5 |
| abstract_inverted_index.potential | 24 |
| abstract_inverted_index.providing | 11 |
| abstract_inverted_index.activities | 28 |
| abstract_inverted_index.management | 9 |
| abstract_inverted_index.population | 7 |
| abstract_inverted_index.real-world | 12 |
| abstract_inverted_index.quantifying | 22 |
| abstract_inverted_index.disease-management | 27 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/10 |
| sustainable_development_goals[0].score | 0.6800000071525574 |
| sustainable_development_goals[0].display_name | Reduced inequalities |
| citation_normalized_percentile.value | 0.95065913 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |